Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State

NCT02549573 is registered in ClinicalTrials.gov with MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals as lead sponsor.

NCT NCT02549573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02549573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outpatient Physical Therapy Intervention in Subjects With Parkinson's DiseaseCurrently Using APOKYN®: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Lead sponsor
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2016
Completion date
December 31, 2016
Enrollment
13 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

motor symptoms, parkinson's disease